The Supreme Court upheld a key plank of Obamacare against a constitutional attack on Friday by a 6–3 vote. But in the process ...

Competing hepatitis C combination drugs from AbbVie and Gilead are now approved in the EU, as the companies aim to treat patients who cannot be cured with established regimens. AbbVie’s Maviret ...

A huge effort to make HCV screening more routine is getting underway. Gilead says 14 million people in the US were screened for the virus for the two-year period of 2014-2015, with around 280,000 ...

Mavyret is an antiviral drug prescribed to treat hepatitis C (HCV). It comes as oral tablets and pellets. Mavyret works by stopping HCV from multiplying, which can cure this condition. Mavyret is ...

Four doctoral students in the Buffalo Neuroimaging Analysis Center (BNAC) recently received significant research awards.

Dr Ashini Fox discusses how NUH's emergency department opt-out BBV testing programme is improving detection and breaking down ...